JPS63159303A - Skin cosmetic - Google Patents
Skin cosmeticInfo
- Publication number
- JPS63159303A JPS63159303A JP30739286A JP30739286A JPS63159303A JP S63159303 A JPS63159303 A JP S63159303A JP 30739286 A JP30739286 A JP 30739286A JP 30739286 A JP30739286 A JP 30739286A JP S63159303 A JPS63159303 A JP S63159303A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- effects
- cosmetic
- calcium
- test
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 21
- JBNULYRBVMNPIS-OWJCAWTQSA-L calcium;4-[[(2r)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]butanoate;hydrate Chemical compound O.[Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCCC([O-])=O JBNULYRBVMNPIS-OWJCAWTQSA-L 0.000 claims abstract description 12
- 229950001260 hopantenic acid Drugs 0.000 claims abstract description 12
- 230000000694 effects Effects 0.000 abstract description 24
- 230000007306 turnover Effects 0.000 abstract description 10
- 102000011782 Keratins Human genes 0.000 abstract description 9
- 108010076876 Keratins Proteins 0.000 abstract description 9
- 239000006210 lotion Substances 0.000 abstract description 8
- 238000002156 mixing Methods 0.000 abstract description 5
- 230000004215 skin function Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 3
- 230000009759 skin aging Effects 0.000 abstract description 3
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 239000006071 cream Substances 0.000 abstract description 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010040849 Skin fissures Diseases 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 54
- 238000012360 testing method Methods 0.000 description 25
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 9
- 229910052791 calcium Inorganic materials 0.000 description 9
- 239000011575 calcium Substances 0.000 description 9
- 210000000434 stratum corneum Anatomy 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 230000032683 aging Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 206010040844 Skin exfoliation Diseases 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 239000002884 skin cream Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229940124277 aminobutyric acid Drugs 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000004299 exfoliation Methods 0.000 description 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 230000036620 skin dryness Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- YTGLSPCIFCDMGL-UHFFFAOYSA-N [Ca].[Ca].O Chemical compound [Ca].[Ca].O YTGLSPCIFCDMGL-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 206010008129 cerebral palsy Diseases 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000000736 corneocyte Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000011977 language disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
(技術分野)
本発明は、ホパンテン酸カルシウムを配合してなる皮膚
老化防止効果(荒肌改善効果、角質改善効果、角質層の
ターンオーバーを速くする効果、美肌効果等)の優れた
皮膚化粧料に関する。Detailed Description of the Invention (Technical Field) The present invention provides skin anti-aging effects (improving rough skin, improving keratin, accelerating the turnover of the stratum corneum, beautifying skin, etc.) by incorporating calcium hopanthenate. ) concerning excellent skin cosmetics.
(従来技術)
老化皮膚とは、乾燥して滑らかさのない荒れ肌で、角質
細胞の剥離現象が認められ、結合組織はコラーゲン/エ
ラスチン比が高く、しわが多い。(Prior Art) Aging skin is rough skin that is dry and lacks smoothness, exhibits peeling of corneocytes, has a high collagen/elastin ratio in connective tissue, and has many wrinkles.
また、老化皮膚は細胞代謝の低下により角質層のターン
オーバーが遅く、従って皮膚に老化防止効果が付与発現
するとターンオーバーが速くなると言われ、種々の皮膚
細胞賦活成分が研究されている。Furthermore, in aging skin, the turnover of the stratum corneum is slow due to a decline in cell metabolism, and therefore, it is said that the turnover becomes faster when an anti-aging effect is imparted to the skin, and various skin cell activating ingredients are being studied.
また、本発明者は、特公昭5B−26726号公報に記
載の如く、γ−アミノ酪酸及びその誘導体を配合してな
る化粧料を提案したが実用上に於いて、皮膚の&tl織
機能を修復または改善し、皮膚が元来保有する機能を回
復して皮膚の老化防止効果に著効を示す程度に改良され
た皮膚化粧料を得ることが困難であった。In addition, the present inventor proposed a cosmetic composition containing γ-aminobutyric acid and its derivatives, as described in Japanese Patent Publication No. 5B-26726, but in practical use, it has not been found that the &tl tissue function of the skin can be restored. Alternatively, it has been difficult to obtain skin cosmetics that have been improved to the extent that they can restore the functions originally possessed by the skin and exhibit remarkable anti-aging effects on the skin.
(発明の開示)
そこで、本発明者は、上記の事情に鑑み鋭意研究した結
果、ホパンテン酸カルシウムは、前記T−アミノ酪酸及
びその誘導体よりも更に一段と皮膚機能亢進作用に優れ
ていることを見出し、史には、ホパンテン酸カルシウム
を配合してなる皮膚化粧料は老化皮膚のターンオーバー
を速め荒肌改善効果、角質改善効果に著効を呈すると共
に皮膚に湿潤性(しっとり感)、柔軟性(滑らか惑)、
弾力性(張り)及び艷を付与し得る美肌効果をも発現す
ることを確認、して本発明を完成するに至った。(Disclosure of the Invention) Therefore, as a result of intensive research in view of the above circumstances, the present inventor found that calcium hopanthenate has an even more excellent skin function enhancing effect than the above-mentioned T-aminobutyric acid and its derivatives. History has shown that skin cosmetics containing calcium hopanthenate accelerate the turnover of aging skin, exhibiting remarkable effects on improving rough skin and keratin, as well as providing moisture (moist feeling) and flexibility to the skin ( smooth),
The present invention was completed by confirming that it also has a beautifying effect that imparts elasticity (tension) and elasticity to the skin.
(発明の目的)
即ち、本発明の目的は、皮膚老化防止効果(荒肌改善効
果、角質改善効果、角質層のターンオーバーを速くする
効果、美肌効果等)の優れた皮膚化粧料を提供すること
にある。(Object of the Invention) That is, the object of the present invention is to provide a skin cosmetic with excellent skin aging prevention effects (improving rough skin, improving keratin, accelerating the turnover of the stratum corneum, beautifying skin, etc.). There is a particular thing.
(発明の構成)
本発明は、ホパンテン酸カルシウムを配合してなる皮膚
化粧料である。(Structure of the Invention) The present invention is a skin cosmetic containing calcium hopanthenate.
(構成の具体的な説明)
本発明に用いるホパンテン酸カルシウムは公知の物質で
あって、その薬理効果としてはブドウ糖の脳内取り込み
及びその代謝を促進させる作用があり、脳炎後遺症や脳
性麻痺などに随伴する多動、注意力低下、言語障害の治
療に有効であり、副作用も少ない薬剤であることが知ら
れている。(Specific explanation of the composition) Calcium hopantenate used in the present invention is a known substance, and its pharmacological effect is to promote the uptake of glucose into the brain and its metabolism, and it is effective against aftereffects of encephalitis, cerebral palsy, etc. It is known to be effective in treating accompanying hyperactivity, decreased attention, and language disorders, and to have few side effects.
ホパンテン酸カルシウムに関する化学的性格等は下記の
通りである。The chemical characteristics of calcium hopantenate are as follows.
(1)構造
(上記構造式のR3はHOCH、基を、R2はN HC
Hz CHt CHz COO基を表わす。)(2)化
学名
カルシウムD−(+)−4−(2,4−ジヒドロキシ−
3,3−ジメチル ブチロアマイド)ブチレイト ヘミ
ハイドレイト
Ca l c i um D−(+) −4−(2,
4−dihydroxy−3,3−dimethylb
utyrate hemihydrat(3) −1
1Q名:ホバンテン酸カルシウム(Calcium
hopantenate)(4)分子式:C2゜H,、
CaNO3”/!H!0(5)分子量:513.60
(6)融点 : 155−165°C
本発明の皮膚化粧料に配合せるホパンテン酸カルシウム
は、メタノール40m1に金属ナトリウム400+gを
加え、加温して懸濁溶液とし、これにT−アミノ酪酸1
.2gを加えて溶解した0次いてバントラクトン1.3
gを加えて2時間撹拌の後、−夜装置、溶媒を留去し析
出せる白色結晶に水を加え不溶物を遠沈除去してから、
水を蒸散させ、乾燥後白色結晶状のホパンテン酸カルシ
ウムを得た。(1) Structure (R3 in the above structural formula is HOCH, R2 is NHC
Hz CHt CHz Represents COO group. ) (2) Chemical name Calcium D-(+)-4-(2,4-dihydroxy-
3,3-dimethyl butyroamide) butyrate hemihydrate Calcium D-(+) -4-(2,
4-dihydroxy-3,3-dimethylb
utyrate hemihydrat(3) -1
1Q name: Calcium fobantenate (Calcium
hopantenate) (4) Molecular formula: C2°H,,
CaNO3”/!H!0 (5) Molecular weight: 513.60 (6) Melting point: 155-165°C Calcium hopantenate to be added to the skin cosmetic of the present invention is prepared by adding 400+ g of sodium metal to 40 ml of methanol and heating. to make a suspension solution, to which 1 t-aminobutyric acid was added.
.. Add 2g and dissolve 0 then vantolactone 1.3
After stirring for 2 hours, the solvent was distilled off, water was added to the precipitated white crystals, and insoluble matter was removed by centrifugation.
Water was evaporated and, after drying, white crystalline calcium hopantenate was obtained.
上記合成法によって得られたホパンテン酸カルシウムを
本発明の諸試験に用いた。Calcium hopantenate obtained by the above synthesis method was used in various tests of the present invention.
本発明の皮膚化粧料中に配合せる上記ホパンテン酸カル
シウムは、皮膚の血行を促進して皮膚機能を冗進し、皮
膚が本来備えている機能を修復或いは改善して皮膚を健
常な状態に保持し、特に老化皮膚に適用する場合顕著な
効果が認められる。The calcium hopantenate incorporated into the skin cosmetics of the present invention promotes blood circulation in the skin, enhances skin functions, restores or improves the skin's inherent functions, and maintains the skin in a healthy state. However, remarkable effects are observed especially when applied to aging skin.
ホパンテン酸カルシウムの配合量は、本発明の皮膚化粧
料の組成物の全重量に対して0.05〜2.0重量%(
以下wt%と略記する)であればよく、好ましくは0.
1〜1.5wt%である。The blending amount of calcium hopantenate is 0.05 to 2.0% by weight (based on the total weight of the skin cosmetic composition of the present invention).
(hereinafter abbreviated as wt%), preferably 0.
It is 1 to 1.5 wt%.
配合量が0.05wt%未満では、本発明の目的とする
効果に充分でな(、一方2.Owt%を越えても、その
増加分に見合った効果の向上は望めないものである。If the blending amount is less than 0.05 wt%, it is not sufficient to achieve the desired effect of the present invention (on the other hand, even if it exceeds 2.0 wt%, an improvement in the effect commensurate with the increase cannot be expected.
本発明の皮膚化粧料は、例えば、ローシロン類、乳液類
、クリーム類、パック類等に適用することができる。The skin cosmetics of the present invention can be applied to, for example, lotions, emulsions, creams, packs, and the like.
尚、本発明の皮膚化粧料には上記の他に色素、香料、防
腐剤、界面活性剤、顔料、抗酸化剤等を本発明の目的を
達成する範囲内で適宜配合することができる。In addition to the above, pigments, fragrances, preservatives, surfactants, pigments, antioxidants, and the like may be appropriately incorporated into the skin cosmetic of the present invention within a range that achieves the object of the present invention.
(実施例)
以下、実施例及び比較例に基づいて本発明の詳細な説明
する。(Examples) Hereinafter, the present invention will be described in detail based on Examples and Comparative Examples.
尚、荒肌 改善効果試験、角質改善効果試験、角質層の
ターンオーバー測定試験、官能テスト(美肌効果試験)
は下記の通りである。In addition, rough skin improvement effect test, keratin improvement effect test, stratum corneum turnover measurement test, sensory test (skin beautification effect test)
is as follows.
(1)荒肌改善効果試験
下脚に荒れ肌を有する中高年被験者20名を対象として
4週間連続塗布効果を調べた。被験者の左側下脚試験部
位に1日1回約1gの試料を塗布し、試験開始前及び終
了後の皮膚の状態を下記の判定基準により判定した。右
側下脚は試料を塗布せず対照とした。(1) Effect test on improving rough skin The effect of continuous application for 4 weeks was investigated on 20 middle-aged and elderly subjects who had rough skin on their lower legs. Approximately 1 g of the sample was applied to the test site of the left lower leg of the subject once a day, and the condition of the skin before and after the test was judged according to the following criteria. No sample was applied to the right lower leg, which served as a control.
皮膚乾燥度の判定基準
−:正常
± :軽微乾燥、落屑なし
+ :乾燥、落屑軽度
++;乾燥、落屑中等度
+++:乾燥、落屑顕著
試験前後の試験部位と対照部位の判定結果を比較し、皮
膚乾燥度が2段階以上改善された場合(例えば、+→−
1++→±)を有効、1段階改善された場合をやや有効
、変化がなかうた場合を無効とした。試験結果は有効、
やや有効となった被験者の人数で示した。Judgment criteria for skin dryness -: Normal ±: Slight dryness, no flaking +: Mild dryness, flaking ++; Moderate dryness, flaking +++: Significant dryness, flaking Comparing the judgment results of the test site and control site before and after the test, If the skin dryness has improved by two or more levels (e.g. +→-
1++→±) was considered valid, one level improvement was considered somewhat effective, and no change was considered invalid. Test results are valid;
It is shown by the number of subjects who were somewhat effective.
(2)角質改善(角質細胞の抗剥離性増大)効果試験
前述の荒肌改善効果試験開始前及び終了後の被験者皮膚
にスコッチテープにチバンメンディングテープ)を接着
し、これを剥離した時テープに付着した角質細胞の状態
を走査型電子顕微鏡によって詳細に調べ、下記の基準に
よって皮膚角質細胞抗剥離性を解析し、角質改善効果を
求めた。(2) Effect test on improving keratin (increasing anti-exfoliation properties of keratinocytes) Scotch tape (Tiban mending tape) was adhered to the subject's skin before and after the above-mentioned rough skin improvement effect test, and when the tape was peeled off. The condition of the keratinocytes attached to the skin was examined in detail using a scanning electron microscope, and the skin keratinocyte anti-exfoliation property was analyzed according to the following criteria to determine the keratin improving effect.
角質改善効果(角質細胞抗剥離性増大)の判定基準
評価点1ニスケールを認めず
2:小スケール点在
3:小物中スケール顕著
4:大スケール顕著
評価は4週間連続塗布後の試験部位の評価点と対照部位
のそれとの差が2点以上の場合を有効、1点の場合をや
や有効、0点の場合を無効とした、判定結果は有効、や
や有効となった被験者の人数で示した。Judgment criteria for keratin improvement effect (increased anti-desquamation property of keratinocytes) Evaluation points: 1 No two scales observed 2: Small scales dotted 3: Small scales noticeable 4: Large scales noticeable Evaluation is evaluation of the test area after 4 weeks of continuous application If the difference between the score and the control site is 2 or more points, it is considered valid, if it is 1 point, it is considered somewhat effective, and if it is 0 points, it is invalid. Judgment results are shown by the number of subjects who found the test to be valid or slightly effective. .
(3)角質層のターンオーバー測定試験蛍光色素のダン
ジルクロライドを白色ワセリン中に5g重量%配合した
軟膏を作り、被験者20名の前腕部の皮膚に24時間閉
塞貼付し、角質層にダンジルクロライドを浸透結合させ
る。その後同じ部位に1日2回(朝・夕)試験試料を塗
布し、毎日ダンジルクロライドの蛍光を調べ、その蛍光
が消滅するまでの日数を皮膚角質層のターンオーバーと
した。(3) Test for measuring the turnover of the stratum corneum An ointment containing 5 g of the fluorescent dye Danzyl chloride in white petrolatum was prepared, and the ointment was applied to the skin of the forearms of 20 subjects for 24 hours. Osmotic binding of chloride. Thereafter, the test sample was applied to the same area twice a day (morning and evening), and the fluorescence of danzyl chloride was checked every day, and the number of days until the fluorescence disappeared was defined as the turnover of the stratum corneum of the skin.
判定結果は被験者の日数の平均値で示した。尚、通常の
皮膚角質層のターンオーバーは14〜16日であるが、
老化した皮膚においては18日前後にのびる。それに対
して老化防止効果が現れると12日前後にまで短縮され
る。The judgment results were shown as the average value of the number of days of the subjects. Note that the normal turnover of the stratum corneum of the skin is 14 to 16 days,
In aging skin, it lasts for about 18 days. On the other hand, if the anti-aging effect appears, the time will be shortened to around 12 days.
(4)官能テスト(美肌効果試験)
荒れ肌、小皺、乾燥肌等を訴える女子被験者(35〜5
5才)20人に試料を1日2回(朝・夕)連続3ケ月後
の効果を評価した。試験結果は、皮膚の湿潤性、平滑性
、弾力性の各項目に対して、皮膚に潤いが生じた、皮膚
が滑らかになった、皮膚に張りが生じたと回答した人数
で示した。(4) Sensory test (skin beautification effect test) Female subjects (35-5
The effects were evaluated after 3 consecutive months of administering the sample to 20 children (5 years old) twice a day (morning and evening). The test results were shown by the number of people who answered that their skin was moisturized, smoothed, or taut for each item of skin wettability, smoothness, and elasticity.
比較例1〜5、実施例1.2
〔二層型スキンローション〕
下記の組成の如く、二層型スキンローション基剤にホパ
ンテン酸カルシウムを第1表に記載の通りに配合して各
々のスキンローションを調製し、前記諸試験を実施した
。Comparative Examples 1 to 5, Example 1.2 [Two-layer skin lotion] Each skin lotion was prepared by blending calcium hopanthenate into a two-layer skin lotion base as shown in Table 1, as shown in the composition below. A lotion was prepared and the tests described above were conducted.
(1)組成
(2) !jl製法
(C)成分のホパンテン酸カルシウムを予め(B)成分
中に混合溶解し、(A) 、(B)成分を各々均一に溶
解した後、(A)成分と(B)成分を混合撹拌分散し、
次いて容器に充填する。生じには内容物を均一に振盪分
散して使用する。(1) Composition (2)! jl Manufacturing method Calcium hopantenate, component (C), is mixed and dissolved in component (B) in advance, and after each component (A) and (B) is uniformly dissolved, the (A) component and (B) component are mixed and stirred. dispersed,
Then fill the container. When using, shake and disperse the contents uniformly.
(3)特性
各二層型スキンローシランの諸試験を実施した結果を第
1表右欄に記載した。(3) Characteristics The results of various tests conducted on each two-layer skin low silane are listed in the right column of Table 1.
比較4M 1.2のホバンテン酸カルシウムを配合して
いないスキンローションに比較して、本発明の皮膚化粧
料は諸試験に於いて良好な結果が認められた。Compared to the skin lotion containing no calcium fobantenate (Comparative 4M 1.2), the skin cosmetic of the present invention gave better results in various tests.
ホパンテン酸カルシウムは、T−アミノ酪酸より一段と
優れた皮膚機能九進作用を有することが明らかであった
。It was clear that calcium hopanthenate had a much better skin function 90 effect than T-aminobutyric acid.
実施例6〜9、比較例3.4
[スキンクリーム〕
実施例1と同様に、下記の組成にて各々のスキンクリー
ムを調製し、諸試験を実施した結果を第1表右欄に示し
た。Examples 6 to 9, Comparative Example 3.4 [Skin Cream] Similarly to Example 1, each skin cream was prepared with the following composition and various tests were conducted. The results are shown in the right column of Table 1. .
(1) 11成
(2)調製法
(C)成分のホパンテン酸カルシウムは(B)成分中に
配合して、(^) 、 (B)成分を各々80°Cに加
熱熔解した後、混合して撹拌しつつ30℃まで冷却して
各スキンクリームを調製した。(1) Preparation method (2) Preparation method Calcium hopantenate (C) component is blended into (B) component, (^) After heating and melting each (B) component at 80°C, they are mixed. Each skin cream was prepared by cooling to 30°C while stirring.
(3)特性
第1表に示す如く、本発明の皮膚化粧料である実施例6
〜9のスキンクリームは、比較例3.4と比較して緒特
性の全てに亘って優れていることは明らかであり、配合
特性に於いても異常は認められなかった。(3) Characteristics As shown in Table 1, Example 6 is a skin cosmetic of the present invention.
It is clear that the skin creams No. 9 to 9 are superior in all properties compared to Comparative Example 3.4, and no abnormality was observed in the blending properties.
(発明の効果)
以上記載の如く、本発明の皮膚化粧料は、皮膚機能を充
進し、皮膚の老化防止に顕著な効果を発現する優れた皮
膚化粧料を提供することが明らかである。(Effects of the Invention) As described above, it is clear that the skin cosmetic of the present invention provides an excellent skin cosmetic that improves skin functions and exhibits a remarkable effect on preventing skin aging.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30739286A JPH062661B2 (en) | 1986-12-22 | 1986-12-22 | Skin cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP30739286A JPH062661B2 (en) | 1986-12-22 | 1986-12-22 | Skin cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS63159303A true JPS63159303A (en) | 1988-07-02 |
JPH062661B2 JPH062661B2 (en) | 1994-01-12 |
Family
ID=17968497
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP30739286A Expired - Lifetime JPH062661B2 (en) | 1986-12-22 | 1986-12-22 | Skin cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH062661B2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06100430A (en) * | 1992-09-22 | 1994-04-12 | Kanebo Ltd | Agent for promoting cornification of cuticle |
FR2924946A1 (en) * | 2007-12-18 | 2009-06-19 | Oreal | COSMETIC USE OF ACID CERAMIDASE-LIKE PROTEINS |
-
1986
- 1986-12-22 JP JP30739286A patent/JPH062661B2/en not_active Expired - Lifetime
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06100430A (en) * | 1992-09-22 | 1994-04-12 | Kanebo Ltd | Agent for promoting cornification of cuticle |
FR2924946A1 (en) * | 2007-12-18 | 2009-06-19 | Oreal | COSMETIC USE OF ACID CERAMIDASE-LIKE PROTEINS |
WO2009077995A1 (en) * | 2007-12-18 | 2009-06-25 | L'oreal | Cosmetic use of acid ceramidase type proteins |
Also Published As
Publication number | Publication date |
---|---|
JPH062661B2 (en) | 1994-01-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3957971A (en) | Moisturizing units and moisturizing compositions containing the same | |
JPH0146483B2 (en) | ||
JPS63150209A (en) | Skin cosmetic | |
JPH0733637A (en) | Skin cosmetic | |
JP2511820B2 (en) | Skin cosmetics | |
JPS63159303A (en) | Skin cosmetic | |
JPS6281307A (en) | Skin cosmetic | |
JP3483984B2 (en) | Cosmetics | |
JP3426400B2 (en) | Cosmetics | |
JP2511817B2 (en) | Skin cosmetics | |
JP2553474B2 (en) | Skin cosmetics | |
JPS62148414A (en) | Skin cosmetic | |
JPH0426606A (en) | Skin cosmetic | |
JPS62255405A (en) | Skin cosmetic | |
JP3534933B2 (en) | External composition for skin | |
JP3939857B2 (en) | Skin cosmetics | |
JP2000264833A (en) | Skin cosmetic | |
JPH05194179A (en) | Skin cosmetic | |
JPH0363207A (en) | Skin cosmetic | |
JP3001942B2 (en) | Skin cosmetics | |
JP2000143598A (en) | Ceramide derivative and skin cosmetic containing the same | |
JPH0764701B2 (en) | Skin cosmetics | |
JP3853097B2 (en) | Topical skin preparation | |
JP2977734B2 (en) | Skin cosmetics | |
JP2977683B2 (en) | Skin cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
EXPY | Cancellation because of completion of term |